Ryan Zimmerman is a Managing Director and Medical Technology Analyst at BTIG. He provides coverage across the medical technology sector, focusing primarily on orthopedic and surgical companies.

Dec 12, 2024 · Ryan Zimmerman is a Wall Street analyst working for BTIG. Ryan has covered 33 stocks with a 62.07% success rate and an average return of 19.08%.

Meet the BTIG Research & Strategy analysts. We know that when it comes to your business, delivering data makes a difference.

Check out this exclusive Hot Seat Interview from the Innovators Pop-Up during AAO 2024, featuring Ryan Zimmerman of BTIG and Anthony Wallace and Andrew Stewa...

Check out this exclusive Hot Seat Interview from the Innovators Pop-Up during AAO 2024, featuring Ryan Zimmerman of BTIG and Robert Chang of Myra Vision. The...

Jul 12, 2019 · Ryan Zimmerman is a Managing Director and Medical Technology Analyst at BTIG. He provides coverage across the medical technology sector, focusing primarily on orthopedic and surgical...

Thrilled to speak at Innovators Pop-Up from LaunchLab Partners ahead of the American Academy of Ophthalmology with Yari Mitchell Bausch + Lomb Atia Vision Myra Vision Oculotix. BTIG is proud to...

Ryan Zimmerman is a 1.33-star Wall Street Analyst at BTIG. Ryan Zimmerman's focuses on the Healthcare sector and covers 43 stocks with a 44.58% success rate.

Oct 7, 2024 · Ryan Zimmerman has given his Buy rating due to a combination of factors including the potential expansion of robotic surgery into emergency general surgery and the growing body of clinical...